Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie

Clinical trial NCT06031233 · RECRUITING

Trial details

NCT number: NCT06031233
Sponsor: Isala
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Oncology Infusion Reaction

Start date: 2023-09-01
Primary completion: 2028-07-01
Enrollment: 776

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.